EQS-News: European Healthcare Acquisition & Growth Company B.V.
/ Key word(s): Half Year Report
Amsterdam, 18 September 2024 Today, European Healthcare Acquisition & Growth Company B.V. ("EHC"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam aiming to acquire one or more companies in the European healthcare sector, publishes its half-year report for the first six months of its financial year 2024 (the "Half-Year Report"), including its unaudited interim condensed financial statements and the interim report of its board. The Half-Year Report can be downloaded from the website of EHC in the 'Investor Relations' section under 'News & Publications': https://ehc-company.com/websites/ehc/English/1300/news-_amp_-publications.html. European Healthcare Acquisition & Growth Company B.V. General Enquiries Media Enquiries FGS Global Kai Peter Rath +49 211 43079 209 Disclaimer This press release contains information that may qualify as inside information within the meaning of Article 7, paragraph 1, of the EU Market Abuse Regulation.
18.09.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | European Healthcare Acquisition & Growth Company B.V. |
c/o ALR Treuhand GmbH; Theresienhöhe 28 | |
80339 München | |
Germany | |
ISIN: | NL0015000K10, NL0015000K28 |
WKN: | A3C60V |
Listed: | Regulated Unofficial Market in Frankfurt, Munich, Stuttgart; Amsterdam |
EQS News ID: | 1990935 |
End of News | EQS News Service |
|
1990935 18.09.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.